Akari Therapeutics Cash Flow Statement (2012-2026) | AKTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2020	Sep2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-0.01B	-0.00B	-0.01B	-0.00B		-0.01B		-0.00B	-0.00B	-0.00B	-0.05B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B
Depreciation and Depletion (Quarter)	0.00B
Share-based Compensation (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Deferred Taxes (Quarter)																		0.00B		-0.00B
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)																		0.01B		0.00B
Non-cash Items (Quarter)	0.00B	-0.00B	0.00B
Cash from Operations (Quarter)	-0.00B	-0.00B	-0.00B					-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)																				0.01B
Depreciation & Amortization (CF) (Quarter)	0.00B	986.00	0.00B					0.00B	0.00B	0.00B	0.00B	0.00B			0.00B
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	0.00B	-0.00B	0.00B					-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)	-0.00B											0.00B		0.00B	-0.00B		0.00B		0.00B
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Short-Term Debt issuances (Quarter)												0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B
Change in Capital Stock
Shares Issued (Quarter)	0.11B		0.11B	0.12B	0.14B	0.38B	0.51B		0.86B		0.00B	0.86B	0.35B	0.51B	6.81B	14.39B	19.17B	7.42B	0.00B	0.15B
Net Equity Issued and Repurchased (Quarter)	0.01B		0.01B		0.01B			0.00B		0.00B	0.00B	0.00B	0.01B	-0.00B	0.00B	0.00B	0.00B		0.00B
Misc.
Cash from Financing Activities (Quarter)	0.01B		0.01B					0.00B	0.00B		0.00B	0.00B	0.01B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B
Exchange Rate Effect (Quarter)	-0.00B	0.00B	-0.00B							-0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B			-0.00B
Change in Cash (Quarter)	0.00B	-0.00B	0.00B					-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B
Free Cash Flow (Quarter)	-0.00B	-0.00B	-0.00B					-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Net Cash Flow (Quarter)	0.00B	-0.00B	0.00B					-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B

Research Tools

Developers

Akari Therapeutics Cash Flow Statement (2012-2026) | AKTX

Research Tools

Developers

Akari Therapeutics Cash Flow Statement (2012-2026) | AKTX

Create an account

Sign In

Reset Password